ReviewHerzschrittmachertherapie & Elektrophysiologie2025
[Endocardial left ventricular pacing in 2025].
Review in Herzschrittmachertherapie & Elektrophysiologie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiac resynchronization therapy (CRT) has gained a new partner in the treatment of systolic heart failure with the possibility of lead system stimulation. In parallel, leadless systems for right ventricular stimulation are being used, particularly in cases of venous access problems, infections, or other complications associated with leads. Endocardial, leadless left ventricular stimulation has been in clinical use for over 10 years now and is continuously being developed. It offers the alternative of stimulating the left ventricle endocardially and leadlessly via a co-implant, either posterolateral-basal or at the left (Tawara) branch of the left ventricular endocardium. This article presents the development, previous challenges, and new approaches to the implantation of the WiSE-CRT system (wireless stimulation endocardially). In addition, the clinical data situation and current approvals will be discussed.
Indexed as
Identifiers
41143996What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.